INTERWEST VENTURE MANAGEMENT CO - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 43 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
INTERWEST VENTURE MANAGEMENT CO ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,224,000
+19.5%
560,9900.0%13.02%
+98.2%
Q2 2022$3,534,000
-24.1%
560,9900.0%6.57%
+269.5%
Q1 2022$4,656,000
+17.3%
560,990
-26.7%
1.78%
-24.2%
Q4 2021$3,970,000
-22.3%
764,9180.0%2.35%
+10.9%
Q3 2021$5,110,000
-21.6%
764,9180.0%2.12%
+2.9%
Q2 2021$6,517,000
-3.7%
764,9180.0%2.06%
+15.4%
Q1 2021$6,770,000
-28.0%
764,9180.0%1.78%
+51.7%
Q4 2020$9,401,000
+51.0%
764,9180.0%1.17%
-34.7%
Q3 2020$6,226,000
-15.2%
764,9180.0%1.80%
-70.5%
Q2 2020$7,343,000
+41.2%
764,9180.0%6.09%
+10.8%
Q1 2020$5,201,000
-54.4%
764,9180.0%5.49%
+11.8%
Q4 2019$11,397,000
+45.4%
764,9180.0%4.91%
+63.3%
Q3 2019$7,840,000
-3.3%
764,9180.0%3.01%
+14.9%
Q2 2019$8,108,000
-24.5%
764,918
-0.4%
2.62%
-73.5%
Q1 2019$10,741,000
-14.9%
768,285
-38.1%
9.87%
-44.3%
Q4 2018$12,617,000
-34.3%
1,241,868
-22.4%
17.72%
+89.0%
Q3 2018$19,195,000
-1.6%
1,599,5920.0%9.37%
+13.7%
Q2 2018$19,515,000
+23.9%
1,599,5920.0%8.24%
+24.2%
Q1 2018$15,756,000
-29.4%
1,599,5920.0%6.64%
-13.0%
Q4 2017$22,314,000
+26.8%
1,599,5920.0%7.63%
+66.5%
Q3 2017$17,596,000
+39.2%
1,599,5920.0%4.58%
+53.1%
Q2 2017$12,637,000
-31.0%
1,599,5920.0%2.99%
-23.1%
Q1 2017$18,315,000
-1.7%
1,599,5920.0%3.89%
-12.4%
Q4 2016$18,635,0001,599,5924.44%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders